McGill University; Montreal Neurological Institute; Neurological and Psychiatric

Montreal, Quebec H3A 2B4

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting, Relapsing Multiple Sclerorsis

Studies at this site

• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed
• Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS) — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed